By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Paris      France
Phone: n/a Fax: n/a


Medical Device

Company News
Nanobiotix Reports Positive Preliminary Results In Head And Neck Cancer Phase I/II Clinical Trial With NBTXR3 6/9/2015 2:33:15 PM
Nanobiotix Revenue For The 1st Quarter Of 2015 5/13/2015 1:06:26 PM
Nanobiotix: 2014 Annual Results 4/14/2015 12:00:34 PM
Nanobiotix Appoints Its Manufacturing Partner, Cordenpharma : Another Step Towards Commercialization 3/18/2015 2:43:39 PM
Nanobiotix 2014 Q4 And Annual Revenues 2/27/2015 11:31:36 AM
Professor Robert Langer Joins Nanobiotix As Scientific Advisor 2/20/2015 7:37:29 AM
Nanobiotix Places Shares And Warrants With U.S. Investor 12/1/2014 2:44:08 PM
Nanobiotix Receives First Approval To Start Phase 2/3 Registration Trial In Soft Tissue Sarcoma In Europe 10/16/2014 7:19:45 AM
Nanobiotix Reaches The Second Milestone Payment Of BPIFrance Dedicated To NBTXR3 Development In Liver Cancers 10/13/2014 9:45:41 AM
PharmaEngine, Inc. Will Join Nanobiotix' Pivotal Trial For NBTXR3 In Soft Tissue Sarcoma To Accelerate Its Development In Asia-Pacific 10/8/2014 7:10:22 AM